RIO DE JANEIRO, BRAZIL - The Butantan Institute has bottled all its available active pharmaceutical ingredient (API) for the CoronaVac, a vaccine against Covid-19 from Chinese Sinovac laboratory, and is now waiting for the arrival of a new lot, expected to be delivered by May 18th, said Butantan's president Dimas Covas.
"The available API was processed in the first phase, which is bottling. It is in quality control until release," said Dimas Covas in . . .